• Top 20 biopharmas' market cap rises 2% in Q3 2024 amid flurry of ...🔍
• The Best Laptops We've Tested 🔍
• Genetic Testing Services Market Size to be worth $12.48 Billion By ...🔍
• After Success in Treating Cancer🔍
• Google DeepMind Open|Sources AlphaFold 3🔍

Top 20 biopharmas' market cap rises 2% in Q3 2024 amid flurry of ...

... Prime's gene-editing reagents based on its PASSIGE technology ... cardiovascular events in the Phase III HELIOS-B trial for ATTR ...

BMS, Merck, Amgen Eye M&A to Tackle Patent Expirations

Top drugmakers face patent expirations, prompting strategic acquisitions and partnerships to mitigate risks and strengthen pipelines.

The Best Laptops We've Tested (November 2024) - PCMag

Whether you want a simple budget PC, a productivity workhorse, or a screamer of a gaming notebook, our deep-dive guide has all the advice you need, plus our top ...

Genetic Testing Services Market Size to be worth $12.48 Billion By ...

... genetic disease, identification of health risks, and personalization of treatment ... gene editing, and genetic testing for cancer, among others.

After Success in Treating Cancer, CAR T Cells Break Into ...

Gene Editing · Cell Therapy · Gene Therapy · Resources · Webinars · White ... Strategy program. A more manageable safety profile can be a ...

Google DeepMind Open-Sources AlphaFold 3: A Game-Changer for ...

... DNA and other molecules, helping scientists better understand and potentially treat diseases. These types of interactions are at the heart ...